Unlike >95% of SCLC tumours and cell lines, SBC-3 cells do not have alterations in RB1 or TP53, nor do they express SCLC-specific neuroendocrine markers, such as CgA, NSE, and synaptophysin (Supplementary Fig. 4d). This evidence concerns the gene ENO2 and neoplasm.